LSI USA '25 Almost at Capacity: Register Today arrow-icon

Overview

Valued at ~$427.2 million in 2023, the external pain pumps market is projected to reach ~$538.3 million by 2028, increasing at a CAGR of 4.7% over the 2023-2028 forecast period. This Market Snapshot is part of LSI’s Market Intelligence platform, your one-stop-shop for global medtech market sizing and analysis, procedure volume data, startup company- and deal-tracking, curated insights, and more.
External pain pumps are designed to provide consistent, long-lasting pain relief by delivering medication intravenously, subcutaneously, or epidurally. These devices utilize subcutaneous or epidural catheters that are tunneled into the patient.
Products included within the scope of this analysis include:
External infusion pumps and related consumables for pain management
This Market Snapshot is intended to provide a high-level overview of the global market for external pain pumps, with key insights into:
Unit volumes from 2023 to 2028
Market forecasts from 2023 to 2028
Market insights
Competitive landscape analysis of major competitors
Insights into key market events for strategic and startups

External Pain Pumps Market Snapshot Summary

Snapshot Aspect Data and Details
Base Year for Estimate 2023
Forecast Period 2023 - 2028
Market Size in 2023 $427.2 million
CAGR 4.7%
Projected Market Size in 2028 $538.3 million

External Pain Pumps Market Insights

The external pain pumps market is primarily driven by the growth in procedure volumes and the increase in the average selling price of pain pumps, largely influenced by inflation. While price increases are expected, they are projected to lag behind the broader medical device market. ​​Pain pumps like the Avanos On-Q and ambIT are commonly used for postoperative pain management, particularly for patients undergoing orthopedic surgeries such as knee and hip replacements.
The adoption of pain pump therapy is anticipated to continue growing—especially in less developed countries where the rate of procedure volume growth is accelerating, and the adoption of new medical technologies is catching up to that in more developed regions. With a 100-year legacy in the market, Avanos remains a market leader in providing advanced solutions for pain management and chronic care solutions.

Competitive Landscape

The full Market Snapshot includes a robust analysis of the competitive landscape for the external pain pumps market. This includes estimated market revenue and market share for key players, such as Avanos, ICU Medical, and B. Braun.
External pain pumps market competitor breakdown.

Select Market Events

Company Date Event Type Event
ICU Medical
8/2023 Regulatory Approval ICU Medical received U.S. FDA clearance for its Plum Duo Infusion Pump and LifeShield Infusion Safety Software.
B. Braun
11/2023 Product Recall B. Braun initiated the Class I recall of its Infusomat Space Volumetric Infusion Pump System due to a faulty occlusion alarm. There have been 51 complaints, one injury, and one death.

Key Companies Covered

Avanos
B. Braun
Baxter
Epic Health
ICU Medical
Medical Flow Systems
MicroPort Scientific
Perceptive Medical
Teleflex

Order individually or subscribe and
get a complete intel platform.

Trusted By The Companies Pioneering What’s Next